FDX03T_FN-170_CL HAVIgM.indd
Contents
1. HAV IgM HAV IgM ALP2. IgM IgM HAV HAV 1 VC 0 0 222 Se 2 IgM HHAV A SPUEHGOT2 LE 3 4 HAV IgM
3. 2830 HAVIgM 2 0mL 1 HAVIgM 2 0mL 1 4 100mLx6 50mLx6 AMPPD 0 2mg mL a 5 1000mLx1 one i 6 300mLx4 80mLx4 1 a di Pt REE 1 15 2 whole virion 2 HAVIgM 3 AMPPD 3 2 spiroadamantane 4 methoxy 4 3 phosphoryloxy pheny1 L 1 2 dioxetane disodium salt 3 2 4
4. HAV IgM HAV IgM HAV IgM
5. 4 1 2 2 1 4 5 10 0 ht TgM HAV 3 4 10 2 5 TgM HAV
6. 4 A T gM HAV A AMPPD CLEIA chemiluminescent enzyme immunoassay 1 1 HAV IgM HAV I gM HAV IgM 2 0 2 3
7. 20 3 6 CV 10 2 1 2 6 7 R IA 1 a 106 2 108 1 158 159 107 160 267 98 9 264 267 3 EIA 2 55
8. 1 C 1 C I C O 1 S C C HAVTIgM X1 2 C O I 1 0 C O TI 1 0 3 1 HAV 2 3
9. HBs HCV HI V 200L 37 C 5 5 HAV I gM TgM HAV A TE 7nm 9 6 HAV IgM HAV HBs AMPPD CV H TV A PE IgM TAV
10. 2 1 FDX03T 1 2 2 10 6 6 6 9 9 9 No 219867 I HAVIgM 42 X 2 HAV IgM 292730 I HAVIgM 1
11. 2 RI 2 0 2 0 53 53 2 53 55 100 55 55 1 1 2 3 4 2 1 2 3 4 7 8 10 11 12 12 3 1 HIV HBV HCV pH10
12. 7 8 1 1 2 0 jr 2 1 250L 3 I gM
13. 2 1 2 3 1 2 HAV IgM 3 4 4 IgM HAV IgM HAV HAV IgM C I
14. 1 1 0 0 05 0 HAV I gM 0 1 1000ppm 1 2 1 1 2 1 C 2 0 1000ppm 1
15. 2 350L ALP HAV 4 H AV EDTA 10mg mL 100U mL 38mg mL 1 y 2 F C 19 5mg dL 21 5mg dL 430mg dL 3 HAVI gM
16. FDX03T 2 FDX03T 2007 10 1 IgM IgM I gM HAV 20700AMZ00226000 HHAVIgM 20 ug 1804L IgM 250 HAVTgM EE 20gL 37 10 A M 8 1 UL I HAVIsM my
17. 4 X 3 HAVIgM 3 219973 100mL X6 292600 50mLX6 219942 1000mL 1 219935 300mLX4 292617 80mLX4 1 ls 4 Meet 103 1403 1412 2006 2 A 421 575 580 2001 3 Nishizono I et al Rapid and sensitive chemiluminescent enzyme 1mmunoassay for measuring tumor markers 37 1639 1644 Chemistry 1991 4 HAVIgM HAVAb 343 1998 5 528 1998 Ma EL 0120 292 832 FAX 03 5695 9234 2 62 5 CLEIA HAVAb HAVI
18. gM HA Clinical 40 2 335 21 523 Applied Biosystems
Download Pdf Manuals
Related Search